Showing results (11-20 of 99) with videos related to
Sort By:
Pageof 10
Discovery Medicine|August 14, 2010
The promise of bispecific antibodiesPeter Kufer, Ralf Lutterbüse, Patrick A BaeuerleCurrent Opinion in Molecular Therapeutics|September 30, 2003
Bispecific antibodies for polyclonal T-cell engagementPatrick A Baeuerle, Peter Kufer, Ralf LutterbüseClinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 19, 2011
EpCAM/CD3-Bispecific T-cell engaging antibody MT110 eliminates primary human pancreatic cancer stem cellsMichele Cioffi, Jorge Dorado, Patrick A Baeuerle, et al.International Immunology|June 17, 2003
Specific depletion of autoreactive B lymphocytes by a recombinant fusion protein in vitro and in vivoMarcel Zocher, Patrick A Baeuerle, Torsten Dreier, et al.Pharmacology & Therapeutics|September 4, 2012
Blinatumomab: a historical perspectiveDirk Nagorsen, Peter Kufer, Patrick A Baeuerle, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 15, 2006
Antitumor activity of a dual cytokine/single-chain antibody fusion protein for simultaneous delivery of GM-CSF and IL-2 to Ep-CAM expressing tumor cellsJuergen M Schanzer, Iduna Fichtner, Patrick A Baeuerle, et al.Cancer Immunity|February 18, 2006
A human cytokine/single-chain antibody fusion protein for simultaneous delivery of GM-CSF and IL-2 to Ep-CAM overexpressing tumor cellsJuergen M Schanzer, Patrick A Baeuerle, Torsten Dreier, et al.Nature Reviews. Immunology|July 1, 2026
T cell engagers in autoimmune diseasesRicardo Grieshaber-Bouyer, Lei Wu, Georg Schett, et al.Plos One|October 29, 2015
Impact of Diverse Immune Evasion Mechanisms of Cancer Cells on T Cells Engaged by EpCAM/CD3-Bispecific Antibody Construct AMG 110Wibke Deisting, Tobias Raum, Peter Kufer, et al.Cancer Metastasis Reviews|June 9, 2020
Expression and function of epithelial cell adhesion molecule EpCAM: where are we after 40 years?Olivier Gires, Min Pan, Henrik Schinke, et al.Pageof 10